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Background: Tuberculous pleural effusions (TPE) are common. The diagnosis is often problem-
atic. As the determination of ADA is often unavailable in some countries, the aim of this study
was to evaluate the diagnostic usefulness of other data from pleural fluid analysis, in young
patients from populations with high prevalence of tuberculosis (TB).
Methods: We analysed 218 patients with pleural effusion (165 tuberculous, 21 infectious, 11
neoplastic, 16 miscellaneous, 3 idiopathic). We performed two regression models; one
included pleural fluid ADA values (model 1), and the other without ADA (model 2).
Results: Model 1 selected two variables (ADA >35 U/L) and lymphocytes (>31.5%) and
correctly classified 216/218 effusions (1 false negative, 1 false positive). Model 2 (without
ADA) selected three variables: lymphocytes (>31.5%), fever and cough, and correctly classified
207/218 effusions (8 false negatives, 3 false positives). The sensitivity of models 1 and 2 was
99.4% and 95.2%, specificity 98.1% and 94.3% and accuracy 99% and 95%.Neumologı´a, Hospital de Conxo, Complexo Hospitalario Clı´nico Universitario de Santiago, Ru´a Dr.
Compostela, A Corun˜a, Spain.
do@sergas.es (L. Valde´s).
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1212 L. Valde´s et al.Conclusions: In geographic areas with high prevalence of TB and a low prevalence of HIV, in
young patients (40 years), it is possible to confidently diagnose TPE with either of the two
regression tree models, with the utility of ADA providing superior sensitivity, specificity, and
accuracy.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
The diagnosis of a tuberculous pleural effusion (TPE)
requires a positive culture (from pleural fluid or pleural
tissue) or the presence of granulomas in the pleura.1
However, we have demonstrated that with the high diag-
nostic yield of adenosine deaminase (ADA), in a region like
ours, with a high prevalence of TPE,2,3 and in a specific
population (less than <35 years), it would be possible to
establish the diagnosis of TPE without the need for a pleural
biopsy. Pleural biopsy should be reserved for patients with
a low pleural fluid ADA, negative cytology and a high
suspicion of a neoplasm.4
Although making the clinical diagnosis is more likely with
the measurement of ADA, its availability may be problem-
atic in some countries 5 and pleural biopsy is not available
in many hospitals. Therefore, the aim of this study was to
evaluate whether in regions with a high prevalence of
tuberculosis and, at least, in young patients (less than <40
years), a confident clinical diagnosis of TPE generated can
be established from clinical data and standard pleural fluid
analysis, with or without a determination of ADA.
Material and methods
We analysed, prospectively, all patients admitted to our
health centre, a 1000-bed teaching hospital in Santiago de
Compostela, Spain from January 2000 to December 2008.
Pleural fluid and peripheral blood samples were
obtained at the same visit, with the patient fasting and the
closed pleural biopsy was obtained by either a Cope6 or
Abrams7 needle. Pleural fluid samples were sent to
cytology, microbiology (for ZiehleNeelsen stain and aerobic
and anaerobic cultures in Lowenstein media), and
biochemistry, which included total protein, lactate dehy-
drogenase (LDH), cholesterol, glucose, ADA, red cell count
and total nucleated cell count with differential. The same
testing was performed on blood samples. All biochemical
measurements were performed on a clinical chemistry
analyser (ADVIA 2400, SIEMENS HEALTHCARE DIAGNOSTICS)
using standard methodology. The ADA activity (U/L at
37 C) was determined colorimetrically by the method of
Galanti and Giusti.8 The NH4
þ released by deamination of
adenosine added to the samples was quantified by incuba-
tion with phenol nitroprusside in an alkaline medium, fol-
lowed by measurement of absorbance at 628 nm. The
within-run precision of this method in our hands was eval-
uated using 30 replicate high ADA samples and 30 replicate
low ADA samples. The corresponding coefficients of varia-
tion were 2.24% for low ADA samples (mean SD:
22.93 0.5 U/L) and 2.02 for high ADA samples
(102.48 2.04 U/L). Between-run precision was evaluated
using 17 pairs of duplicates and a coefficient of variation of2.51% (37.29 0.94 U/L) was obtained.4 Red cell and total
nucleated cell counts were determined by a Haematology
analyser (ADVIA 2120, SIEMENS HEALTHCARE DIAGNOSTICS).
Neutrophilic and lymphocytic effusions were defined as
effusions with a neutrophil or lymphocyte count >50% of
the total nucleated cell count. An effusion was considered
eosinophilic if the cell count was 10%. Only the first
pleural fluid chemistry panel was used for statistical anal-
ysis in patients with more than one thoracentesis.
Clinical parameters recorded were age, sex, chest pain,
cough, sputum, dyspnoea and fever. The radiological find-
ings that were determined were: 1) pulmonary lesion and
its location; 2) laterality of the effusion (right, left, or
bilateral); 3) and the size of the effusion: (large if >2/3 of
the hemithorax, medium if >1/3 and <2/3 of the hemi-
thorax, or small if it was <1/3). A tuberculin skin test was
performed with 2 U of RT-23 and was considered positive if
the induration of the transverse axis of the forearm was
5 mm measured at 48e72 h. With suspected HIV, serology
was also obtained. Thoracoscopy was not performed on any
patient.
The pleural fluid was classified as tuberculous if the
ZiehleNeelsen stain or the Lowenstein culture was positive
in pleural fluid or biopsy, or if granulomas were identified
on biopsy.
An effusion was diagnosed as neoplastic only when
confirmed by positive cytology in pleural effusion or pleural
biopsy. An effusion was considered parapneumonic if there
was bacterial pneumonia, a lung abscess or bronchiectasis
or if the pleural fluid culture was positive. An empyema was
diagnosed if the fluid was purulent. The other diagnoses
were based on previously established criteria.1Statistical analysis
Data are expressed as mean SD. The Student t test was
used for the comparison of the continuous variables
between TPE and the rest of the groups, and the Manne
Whitney test was used if the distributions were not normal.
The chi-squared analysis was used for comparison of
proportions. The results of the diagnostic tests were
expressed as sensitivity, specificity, predictive values
(positive and negative), positive likelihood ratio, negative
likelihood ratio and accuracy, with 95% confidence intervals
(95% CI). ROC (receiver operator characteristics) curve
methodology was used to find the optimum cut-point.
We performed two regression tree models. The first
included the ADA level in pleural fluid (model 1) while the
second (model 2) did not include ADA. The statistical
modelling used analysis adjusted for the following cova-
riates: gender, fever, chest pain, dyspnoea, cough, sputum,
size and location of the effusion, accompanying pulmonary
lesions, tuberculin skin test, red and total nucleated cell
Table 1 Causes, gender, and age at diagnosis of pleural effusions.
n % Males/females Age, yrsa
Tuberculosis 165 75.7 91/74 23.9 6.5
Infectious 21 9.6 16/5 31.1 7.7
Neoplastic 11 5 9/2 35.7 2.5
Miscellaneous 16 7.3 13/3 32.8 4.9
Post-surgery 5 2.3
Pancreatitis 4 1.8
Pleuropericarditis 4 1.8
Systemic lupus erythematous 1 0.5
Pulmonary thromboembolism 1 0.5
Liver cirrhosis 1 0.5
Idiopathic 5 2.3 3/2 27.8 5.3
Total 218 100 132/86 25.9 7.3
a Mean standard deviation.
Diagnosing tuberculous pleural effusion 1213counts, lymphocytes (%), neutrophils (%), glucose, pleural
fluid/serum protein ratio (P/S protein ratio), lactate
dehydrogenase (LDH) and pleural fluid/serum LDH ratio
(P/S LDH ratio). In the tree-based analysis, the final
regression tree was derived using the CART approach.9 This
involved successive binary partitioning of the data set by
identifying at each partition the explanatory variable which
maximized the between groups sum-of-squares using anal-
ysis of variance. All statistical test values were two-sided,
and a P value of <0.05 was considered to be statistically
significant. Analysis was carried out using SPSS (15.0) and R
statistical software.
Results
The 218 patients (60% males) with a mean age of 26 years
and their diagnoses are listed in Table 1. A definitive
diagnosis could not be established in five patients (2.3%). As
expected, among our patients with pleural effusions aged
<40 years, the prevalence of tuberculous effusions was
high (75.7%, 165/218) compared to patients of all ages
(25%) with effusions in this region.2 The prevalence of
neoplastic effusions was low at 5% (11/218) compared with
22.9% for patients of all ages with effusions.2 The infectious
effusion group consisted of the parapneumonic effusions
and empyemas.
Table 2 summarizes the microbiology and histology of
the 165 patients who had at least one positive test for
tuberculous pleural effusions. The most frequent findingTable 2 Microbiological and histological findings for
a tuberculous pleural effusion (nZ 165).
Criteria n %
Observation of caseating granulomas 134/165 81.2
Culture of biopsy tissue in
Lowenstein medium
83/165 50.2
Culture of pleural fluid in
Lowenstein medium
53/165 32.1
ZiehleNeelsen staining
of biopsy tissue
38/165 23
ZiehleNeelsen staining
of pleural fluid
8/165 4.8(81.2%, 134/165) was the observation of caseating granu-
lomas in biopsy tissue. In the 11 patients with a neoplastic
effusion, cytology was positive in 7 (63.6%) cases and
pleural biopsy was positive in 6 (54.5%).
Table 3 shows the clinical data and Table 4 depicts the
laboratory data of the tuberculous and non-tuberculous
pleural effusions.
In 95.2% of the TPE (157/165) the percentage of
lymphocytes was 50%, while only one TPE had a lympho-
cyte percentage count 32%. Ninety-five percent (20/21) of
the infectious effusions had more than 50% neutrophils,
compared to only 1.8% (3/165) of the TPE. Only 4 patients
(3 TPE and 1 infectious) had 10% eosinophils.
The ADA values for all the cases studied, according to
diagnostics, are seen in Fig. 1. A cut-off point 35 U/L, was
associated with an area under the curve of 0.909 and
a sensitivity of 100% (165/165). In contrast, 42 of 53 of the
non-tuberculous effusions had ADA values less than the cut-
off point (specificity 79.2%; 95% CI: 68.3e90.2%). The 11
false positives were found with ten infectious effusions and
one neoplastic effusion (positive by cytology and pleural
biopsy). Given that the prevalence of the disease is 75.7%,
the positive predictive value, positive likelihood ratio,
negative likelihood ratio and accuracy for the diagnosis of
a TPE were 93.8% (95% CI: 90.2e97.3%), 100%, 4.8 (95% CI:
2.8e8.1%), 0.0 and 95% (95% CI: 92%e97.9%), respectively.
Classifying a tuberculous etiology
When the ADA is included in the analysis (ADA >35 U/L;
model 1), the regression model only selected one additional
covariable for the prediction of a TPE: a percentage of
lymphocytes 31.5% (Fig. 2A). With this model, 216 of the
218 effusions were classified correctly (sensitivity 99.4%,
95% CI: 98.2e100%, specificity 98.1%, 95% CI: 94.3e100%).
When ADA was excluded from the multivariate analysis
(model 2), the best regression model selected three
parameters for predicting a TPE: percentage of lympho-
cytes 31.5 and the presence of fever and cough (Fig. 2B).
Applying this model, 207 of the 218 effusions studied would
be classified correctly (8 false negatives and 3 false posi-
tives). This analysis resulted in a sensitivity of 95.2% (95%
CI: 91.9e98.4%) and a specificity of 94.3% (95% CI:
88.1e100%). The diagnostic yield of model 1 (accuracy 99%;
Table 3 Clinical features of patients with tuberculous and non-tuberculous pleural effusions.
Characteristics Tuberculous
(nZ 165)
Malignant
(nZ 11)
Infectious
(nZ 21)
Miscellaneous
(nZ 16)
Idiopathic
(nZ 5)
n % n % p n % p n % p n % p
Male 91 55.2 9 81.8 0.1584 16 76.2 0.1097 13 81.3 0.0798 3 60 0.8073
Fever (>37.8 C) 146 88.5 0 0 <0.0001 21 100 0.2087 6 37.5 <0.0001 0 0 <0.0001
Chest pain 126 76.4 0 0 <0.0001 15 71.4 0.8154 6 37.5 0.0023 4 80 0.7276
Dyspnoea 62 37.6 6 54.5 0.4268 6 28.6 0.5714 3 18.8 0.2211 1 20 0.7393
Cough 105 63.6 0 0 0.0001 21 100 0.0019 1 6.3 <0.0001 0 0 0.0157
Sputum 35 21.2 0 0 0.1882 15 71.4 <0.0001 0 0 0.0856 0 0 0.5526
Massive
effusions
24 14.5 1 9.1 0.9595 0 0 0.1277 0 0 0.2119 0 0 0.7903
Right-sided
effusions
100 60.6 3 27.3 0.0637 12 57.1 0.9426 10 62.5 0.9049 3 60 0.6618
Bilateral
effusions
0 0 4 36.4 <0.0001 2 9.5 0.0043 0 0 1.000 0 0 1.000
Lung lesion 25 15.2 0 0 0.3416 21 100 <0.0001 3 18.8 0.9855 0 0 0.7610
Tuberculin
skin test
121 73.3 4 36.4 0.0201 4 19.0 <0.0001 3 18.8 <0.0001 2 40 0.2422
1214 L. Valde´s et al.95% CI: 97.8e100%) was significantly higher than that of
model 2 (accuracy 95%; 95% CI: 92e97.9%) (P< 0.001).Discussion
The results of our study demonstrate that, in young patients
(40 years), and in regions with a high prevalence of tuber-
culosis, it is possible to establish the diagnosis of TPE from
clinical data and pleural fluid analysis with high ‘‘diagnostic
safety’’. Although both models had a high yield (an accuracy
of 99% for the ADA and 95% for the non ADA-model), the ADA-
model had significantly better accuracy (P< 0.001).
Although the measurement of ADA in pleural fluid for the
diagnosis of a tuberculous effusion is increasing, analysis of
biopsy tissue is often considered obligatory for the defini-
tive diagnosis.10 However, in small hospitals, pleural biopsy
is not always available and the patient has to be transferred
to a tertiary care hospital. Following a study by our group,4
it has been accepted that the test diagnostic value of ADA
in diagnosing TPE is highly accurate and able to avoid
pleural biopsy in young patients from areas with high
prevalence of tuberculosis.11e13 Since the determination of
ADA is problematic in some countries,5,14 several authors
have used complex statistical models to establish the
diagnosis of TPE from a series of clinical features, radio-
logical variables, and the biochemical analysis of the
pleural fluid.14e16 We have accomplished this using a simple
regression tree.
As a result of the epidemiological characteristics of
tuberculosis in our region, its prevalence among cases of
pleural effusion is high at 25%.2 As was expected, given the
young age of the population studied, the prevalence of TPE
in our series was high (75.7%), since the mean age of TPE
varies between 32 and 34 years.2,17,18 Therefore, we
reasoned that the positive predictive value of pleural fluid
levels for ADA for tuberculous pleural effusions should be
better than in regions of lower prevalence, particularly
among patients with a low probability of neoplasia.The diagnostic yield of each of the criteria used to
establish the definitive diagnosis of TPE was similar to that
in previous studies by our group.4,18 The percentage of
patients with fever (88.5%), chest pain (76.4%) and cough
(63.6%) was similar to that reported in the older litera-
ture.19 We did not find any differences in the published
literature on the size and laterality of the effusions, the
existence of lung lesions and the number of positive
tuberculin skin tests.18 Only one neoplastic effusion, diag-
nosed both by cytology and pleural biopsy, had increased
ADA values. Previously, we reported that pleural biopsy
should be performed in those cases where the ADA levels
are lower than the cut-off point, pleural fluid cytology is
negative and, in the absence any data that would lead us to
another diagnosis, or if a neoplasm is suspected.4 With this
approach, those cases with malignancy with negative
cytology and high pleural concentrations of ADA should not
be misdiagnosed. It is necessary to stress ‘‘should’’, as it is
estimated that the 66% sensitivity of cytology for neoplastic
effusions is only increased to 73% if both biopsy and
cytology are used.1 It is questionable whether any of the
patients representing up the 7% difference would have high
pleural concentrations of ADA.
As was reported,19 there were 8 (4.8%) TPE cases with
a percentage of lymphocytes lower than 50% and only one
(0.6%) had 32% lymphocytes. It is possible that the time of
progression of this effusion (10% lymphocytes, 70% neutro-
phils) was short, since neutrophils can be predominant
early in these cases.13
When we used the regression trees, the model that
included the determination of ADA (model 1) only evalu-
ated two variables: ADA (primary variable) and the
percentage lymphocytes. The cut-off points were 35 U/L
and 31.5%, respectively. With this cut-points, the model
with the primary variable ensured a sensitivity of 100% for
the diagnosis of TPE (lowest ADA value in these effusions
was 36 U/L), with the majority of neoplastic effusions also
being correctly classified. With the second variable, we
attempted to separate those infectious effusions that also
Table 4 Pleural fluid analysis of patients with tuberculous and non-tuberculous pleural effusions.
Characteristics Tuberculous Malignant Infectious Miscellane us Idiopathic
x SD Range x SD Range p x SD Range p x SD Range p x SD Range p
Pleural RBC
count, 109/L
4574 16,331 300e
200,000
5829 1020 4760e
7560
0.7994 2599 2161 390e
7800
0.5810 1703 225 150e
8000
0.4838 824 104 700e
980
0.6089
Pleural WBC
count, 109/L
3947 6694 27e
77,000
1449 453 780e
230
0.2188 13,753 16,695 2900e
56,700
<0.0001 1382 150 100e
5230
0.1289 2112 1045 360e
3000
0.5420
Pleural
lymphocytes, %
79.22 14.71 10e100 69.4 14.5 30e85 0.0333 20.6 4.4 0-70 <0.0001 50.8 26. 15e80 <0.0001 51.6 25.5 23e
75
0.0001
Pleural
neutrophils, %
14.32 12.01 1e70 17.4 16.0 8e65 0.4215 68.9 16.7 20-98 <0.0001 42.3 26. 16e28 <0.0001 41.0 22.2 20e
65
<0.0001
Pleural
glucose, mg/dL
70.0 12.1 9e116 87.7 5.00 79e95 <0.0001 64.8 11.7 42-80 0.0548 87.1 6.0 76e98 <0.0001 84.6 5.68 78e
90
0.0085
P/S protein ratio 0.72 0.12 0.13e1.60 0.68 0.07 0.53e
0.75
0.2766 0.75 0.10 0.56e
0.98
0.2739 0.58 0.1 0.14e
0.78
<0.001 0.67 0.09 0.55e
0.77
0.3575
Pleural LDH, U/L 731 938 110e
10,769
584 631 110e
2264
0.6097 1296 2093 130e
10,000
0.6097 323 266 46e
905
0.0855 313 83.4 208e
427
0.3219
P/S LDH ratio 3.64 3.94 0.42e41.0 3.89 4.21 0.73e
15.1
0.8394 8.15 11.9 0.86e
56.6
0.0004 2.15 1.7 0.30e
6.03
0.1367 2.08 0.56 1.38e
2.84
0.3787
Pleural ADA, U/L 118 40.6 36e344 19.0 12.2 7.0e
49.0
<0.0001 70.5 67.4 21e248 <0.0001 19.6 10. 5.0e
33.0
<0.0001 17.4 5.03 12.0e
25.0
<0.0001
RBC: red blood cell; WBC: white blood cell; P/S: pleural fluid to serum ratio.
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Figure 2 Regression trees for predicting tuberculous pleural
effusions (TPE). Model 1 includes ADA (A) and model 2 excludes
it (B). Figures are number of patients at the terminal nodes.
The statistical modelling used in the above analysis adjusted
for the following covariates: gender, fever, thoracic pain,
dyspnoea, cough, sputum, effusions (location and size), lung
lesion, tuberculin skin test, red and white blood cell counts,
lymphocytes (%), neutrophils (%), glucose, P/S protein ratio,
LDH and P/S LDH ratio. In model 1, ADA and lymphocytes (%)
were the covariates kept in the final tree regression model. In
model 2, lymphocytes (%), fever and cough were the covariates
kept in the final tree regression model.
Figure 1 Concentrations (U/L) of adenosine deaminase
(ADA) in 218 patients with pleural effusions. TB: tuberculous
(C); NEO: neoplastics (C); INF: infectious. (C) para-
pneumonic, (6) empyema; MIS: miscellaneous. (,) post-
surgery, (:) pancreatitis, (C) pleuropericarditis, (A)
systemic lupus erythematous, (B) pulmonary thromboembo-
lism, (>) liver cirrhosis; IDI: idiopathics (C).
1216 L. Valde´s et al.had a high ADA, as they are typically predominantly
neutrophils. The only neoplastic effusion in our series that
had a high ADA value also had a lymphocyte percentage of
30%, which was correctly classified with the second vari-
able. With this model, only two effusions were erroneously
classified: a tuberculosis effusion with a low percentage of
lymphocytes and a parapneumonic that had both high ADA
and lymphocyte values. It is likely that the false negative
effusion was sampled early in its course which would
explain the low percentage of lymphocytes; in this case the
fluid culture and the pleural biopsy were diagnostic. The
false positive (a parapneumonic effusion with increased
ADA and percentage lymphocytes) could not be diagnosed
by pleural biopsy. This parapneumonic most likely was
sampled late in its course when the infection was regress-
ing. The diagnostic yield of this model was very high
(sensitivity 99.4%, specificity 98.1%, and accuracy 99%).
This regression tree is supported by the studies of Burgess
and co-workers20 and Diacon and colleagues,21 as these
authors used the same variables to establish the diagnosis
of TPE in their series.
Model 2 of the regression trees (without ADA) used 3
variables; the percentage of lymphocytes (cut-off point
31.5%) as primary variable and the presence of fever and
cough. With the primary variable, the model attempts to
separate the effusions of infectious, non-tuberculous
origin, which should have a low percentage of lympho-
cytes (only one false negative was observed with this vari-
able) and, with fever should eliminate the non-tuberculous
effusions that usually do not present with fever. A total of
20 of the 23 non-tuberculous pleural effusions (three false
positives: a parapneumonic effusion, lupus pleuritis and
pleuropericarditis) and 19 out of 164 tuberculous pleural
effusions did not have fever. Lastly, the third variable
(cough), served to correctly classify the 20 non-TPE that did
not have a fever and the 12 TPE that were febrile. There
did not appear to be an association between cough and the
presence of a pulmonary lesion on chest radiography, as
only 2 of 12 had cough. Seven TPE were not associated withfever or cough (7 false negatives). The pleural biopsy did
not appear to support the diagnosis in the false positives,
although it was positive in the eight false negatives.
It is surprising that the model did not take the tuberculin
skin test into account to discriminate between both groups;
there may be two explanations. As a primary form of
tuberculosis in our region, the tuberculin skin test may be
negative in a high percentage of patients (26.7%). Secondly,
with a high prevalence of tuberculosis, a significant
percentage of patients without a TPE have a positive skin
test. This method correctly classified 207 of the 218 effu-
sions (three false positives and eight false negatives) with
a high diagnostic yield (sensitivity 95.2%, specificity 94.3%,
accuracy 95%), although it was significantly inferior to the
model that included the ADA (P< 0.001).
Carrion and colleagues15 performed a discriminant
analysis using 47 variables (not including ADA) for the
diagnosis of TPE. They studied 78 patients with TPE and 111
with non-TPE. The predictors for the diagnosis of TPE were
Diagnosing tuberculous pleural effusion 1217age, white cell count, tuberculin skin test and bloodstained
exudates; with a sensitivity of 90%, a specificity of 87% and
an accuracy of 88%. Porcel and co-workers14 studied 106
tuberculous and 286 neoplastic effusions. In one model that
included ADA, four variables predicted a tuberculous
etiology: ADA >40 U/L, age <35 years, temperature
>37.8 C and RBC count <5 109/L. In a second model that
excluded ADA, the absence of previous malignancy in the
clinical history and a PF/serum LDH ratio >2.2 was added to
the latter three variables of model 1. A proportional score
was applied to the magnitude of the coefficients of the
logistic equations, with a cut-off point of >5 in model 1 and
>6 in model 2. The two models had a sensitivity of 95% and
97%, a specificity of 94% and 91% and an area under the ROC
curve of 0.987 and 0.982, respectively. Recently Sales et
al.16 established two predictive models for the diagnosis of
pleural effusions secondary to tuberculosis, based on the
numerical score of Porcel and co-workers.14 These authors
propose a model including ADA, globulins and the absence
of malignant cells in the pleural fluid; and another model
including ADA, globulins and fluid appearance, with similar
results in both models (accuracy of 97.7% versus 96.6%).
Our study had three important methodological differ-
ences. The studies by Carrio´n,15 Porcel14 and Sales16 were
performed on a general population, which is why one of the
discriminant variables was age. Also, in the studies of Por-
cel14 and Sales,16 the authors tried to differentiate tuber-
culous from neoplastic effusions, without considering other
effusions. The model by Carrio´n and others15 calculated the
final discriminant function using an impractical equation;
whereas the models by Porcel14 and Sales16 applied a scoring
system that, although proportional to the magnitude of the
coefficients of the logistic equations, was arbitrary. In
a similarway, Dhedaet al. have used abioclinical scoring rule
by assigning a relative score or points to each of the variables
included in the final multivariate model for pleural tuber-
culosis diagnosis.22 However, our regression tree enables the
physician to classify an effusion into TPE or non-TPE using an
easy to perform algorithm. Further studies are needed to
confirm our results; but in theory, they should be reproduc-
ible, since all the variables that were used had a frequency
similar to those previously described, and the yield of ADA
was even lower than in previous studies.4
This study may have some limitations, taking into
account that these results correspond only to a young
population where the likely proportion of TPE cases is very
high, and with low prevalence of HIV infection. Thus, the
high predictive value of the strategies is reflected by
the high prevalence of the disease within the population.
These results may be different in an older population.
In conclusion, in geographic areas with a high prevalence
of tuberculosis and in young patients (<40 years), it is
possible to safely diagnose TPE with either of the two
models that we have studied, although using the ADA is
superior.
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